# The Global Cell Cryopreservation Market is Projected to Grow at a 21.1% CAGR Throughout the Forecast Period

- Published: 2026-11-10
- Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/the-global-cell-cryopreservation-market-is-projected-to-grow-at-a-21-1-cagr-throughout-the/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/

[![Cell Cryopreservation Market](https://www.einpresswire.com/image/medium/1240844/cell-cryopreservation-market.jpeg)](https://www.einpresswire.com/image/large/1240844/cell-cryopreservation-market.png#1024x768)

Cell Cryopreservation Market

[![The Business Research Company](https://www.einpresswire.com/image/medium/236757/tbrc.jpeg)](https://www.einpresswire.com/image/large/236757/tbrc.jpeg#1024x302)

The Business Research Company

*The Business Research Company’s The Global Cell Cryopreservation Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035*

LONDON, GREATER LONDON, UNITED KINGDOM, November 10, 2026 /[EINPresswire.com](https://www.einpresswire.com/)/ -- The cell cryopreservation market has seen remarkable growth recently, driven by advancements in medical and research applications. As the demand for preserved cells rises across various fields, this sector is set to experience significant expansion in the coming years. Let’s explore its current scale, growth factors, regional dynamics, and future outlook in detail.

Size and Growth Projections for the Cell Cryopreservation Market  
The market for cell cryopreservation has expanded rapidly over recent years. Forecasts indicate that it will increase from $15.68 billion in 2025 to $19.42 billion in 2026, representing a strong compound annual growth rate (CAGR) of 23.9%. This upsurge in the past period is largely linked to the growth of biobanking operations, heightened utilization of preserved cells in scientific research, the proliferation of fertility and IVF clinics, wider adoption in regenerative medicine, and improved availability of liquid nitrogen storage technologies.

Download a free sample of the cell cryopreservation market report:  
[https://thebusinessresearchcompany.com/sample\_request?id=24439200&type=smp&name=Cell%20Cryopreservation%20Market%20Report%202026&utm\_source=EINPresswire&utm\_medium=Paid&utm\_campaign=Nov\_PR](https://thebusinessresearchcompany.com/sample_request?id=24439200&type=smp&name=Cell%20Cryopreservation%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR)

Looking ahead, the cell cryopreservation market is expected to continue its exponential growth trajectory. By 2030, the market size is projected to reach $41.82 billion, growing at a CAGR of 21.1%. The forecast period’s expansion is driven by surging demand for cell and gene therapies, increased investments in biopharmaceutical production, advancement in stem cell research, a growing focus on standardized storage methods, and broader use of automated cryostorage systems. Key emerging trends include greater adoption of serum-free cryopreservation media, rising use of controlled-rate freezing equipment, increased need for long-term storage solutions, expansion of [cryobanking infrastructure](https://thebusinessresearchcompany.com/report/cell-cryopreservation-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR), and enhanced efforts to maintain cell viability.

Understanding Cell Cryopreservation and Its Importance  
Cell cryopreservation involves preserving cells by cooling them to sub-zero temperatures, most commonly using liquid nitrogen at around -196°C. This extreme cold effectively stops all biological activity and metabolism within the cells, enabling their long-term storage without degradation. To protect the cells from damage caused by ice crystals forming during [freezing and thawing](https://thebusinessresearchcompany.com/sample_request?id=24439200&type=smp&name=Cell%20Cryopreservation%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR), cryoprotective agents are applied, ensuring cell structures remain intact.

View the full cell cryopreservation market report:  
[https://thebusinessresearchcompany.com/report/cell-cryopreservation-global-market-report?utm\_source=EINPresswire&utm\_medium=Paid&utm\_campaign=Nov\_PR](https://thebusinessresearchcompany.com/report/cell-cryopreservation-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR)

The Growing Impact of Organ Transplant Procedures on Market Expansion  
One of the main drivers of growth in the cell cryopreservation market is the rising number of organ transplant procedures worldwide. Organ transplantation replaces failing or damaged organs with healthy ones from donors, a process that has been increasing due to causes like genetic disorders, infections, injuries, and chronic illnesses. Cryopreservation plays a vital role in this context by freezing and storing cells from organs, which helps maintain their viability, improves transplant success rates, and reduces the risk of immune rejection.

Supporting this trend, data from January 2024 provided by the US federal agency Health Resources and Services Administration shows that in 2023, there were 46,632 organ transplants performed in the United States from both living and deceased donors. This marks an 8.7% increase compared to 2022, clearly demonstrating how growth in transplant procedures is propelling demand for cryopreservation technologies.

Regional Focus and Market Distribution of Cell Cryopreservation  
In 2025, North America held the largest share of the global cell cryopreservation market. However, the Asia-Pacific region is anticipated to exhibit the fastest growth rate throughout the forecast period. The market report covers several key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of regional market dynamics and opportunities.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Speak With Our Expert:  
Saumya Sahay  
Americas +1 310-496-7795  
Asia +44 7882 955267 & +91 8897263534  
Europe +44 7882 955267  
Email: marketing@[tbrc](http://www.thebusinessresearchcompany.com/).info

The Business Research Company - [www.thebusinessresearchcompany.com](http://www.thebusinessresearchcompany.com)

Follow Us On:  
• LinkedIn: [https://in.linkedin.com/company/the-business-research-company](https://in.linkedin.com/company/the-business-research-company)"

Oliver Guirdham  
The Business Research Company  
[+44 7882 955267](<tel:+44 7882 955267>)  
[info@tbrc.info](mailto:info@tbrc.info)  
Visit us on social media:  
[LinkedIn](https://www.linkedin.com/company/the-business-research-company/)  
[Facebook](https://www.facebook.com/TheBusinessResearchCompany/)  
[X](https://twitter.com/tbrc_info)

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

![](https://www.einpresswire.com/tracking/article.gif?aid=954127909&section=einpresswire&a=8o6R7lmjzu4DfBsU&r=Ohkp76qG8AiWTQ6s&i=aI0iAL0UpUZKNJxn)

## Related

- [NuNerve's MND drug NUN-004 faces its first placebo-controlled test after early signs of stabilising disease](https://healthcarenews.io/news/nun-004-phase-2-trial-mnd-placebo-test.md)
- [A lead-212 alpha therapy for neuroendocrine tumors heads to FDA end-of-Phase 2 talks in early 2027](https://healthcarenews.io/news/lead-212-alpha-therapy-nets-fda-talks-2027.md)
- [6 Navigating Conflicting Ethical Considerations in Healthcare Research](https://healthcarenews.io/qa/6-navigating-conflicting-ethical-considerations-in-healthcare-research.md)
- [5 Ethical Considerations in Healthcare Research](https://healthcarenews.io/qa/5-ethical-considerations-in-healthcare-research.md)
